BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23578854)

  • 1. Epigenome-wide association study of breast cancer using prospectively collected sister study samples.
    Xu Z; Bolick SC; DeRoo LA; Weinberg CR; Sandler DP; Taylor JA
    J Natl Cancer Inst; 2013 May; 105(10):694-700. PubMed ID: 23578854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood DNA Methylation and Breast Cancer: A Prospective Case-Cohort Analysis in the Sister Study.
    Xu Z; Sandler DP; Taylor JA
    J Natl Cancer Inst; 2020 Jan; 112(1):87-94. PubMed ID: 30989176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epigenome-wide study of body mass index and DNA methylation in blood using participants from the Sister Study cohort.
    Wilson LE; Harlid S; Xu Z; Sandler DP; Taylor JA
    Int J Obes (Lond); 2017 Jan; 41(1):194-199. PubMed ID: 27773939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants associated with breast-cancer risk.
    Narod SA
    Lancet Oncol; 2011 May; 12(5):415-6. PubMed ID: 21514220
    [No Abstract]   [Full Text] [Related]  

  • 5. [Familial breast cancer, ovarian cancer].
    Inoue M
    Nihon Rinsho; 2006 Jun; Suppl 2():366-70. PubMed ID: 16817423
    [No Abstract]   [Full Text] [Related]  

  • 6. Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk.
    Brennan K; Garcia-Closas M; Orr N; Fletcher O; Jones M; Ashworth A; Swerdlow A; Thorne H; ; Riboli E; Vineis P; Dorronsoro M; Clavel-Chapelon F; Panico S; Onland-Moret NC; Trichopoulos D; Kaaks R; Khaw KT; Brown R; Flanagan JM
    Cancer Res; 2012 May; 72(9):2304-13. PubMed ID: 22374981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic basis of breast cancer and its clinical implications.
    Bennett IC; Gattas M; Teh BT
    Aust N Z J Surg; 1999 Feb; 69(2):95-105. PubMed ID: 10030809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten genes for inherited breast cancer.
    Walsh T; King MC
    Cancer Cell; 2007 Feb; 11(2):103-5. PubMed ID: 17292821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States).
    Jones JS; Gu X; Lynch PM; Rodriguez-Bigas M; Amos CI; Frazier ML
    Cancer Causes Control; 2005 Aug; 16(6):749-53. PubMed ID: 16049814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
    Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
    Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation profiling of archived non-small cell lung cancer: a promising prognostic system.
    Safar AM; Spencer H; Su X; Coffey M; Cooney CA; Ratnasinghe LD; Hutchins LF; Fan CY
    Clin Cancer Res; 2005 Jun; 11(12):4400-5. PubMed ID: 15958624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients.
    Flanagan JM; Munoz-Alegre M; Henderson S; Tang T; Sun P; Johnson N; Fletcher O; Dos Santos Silva I; Peto J; Boshoff C; Narod S; Petronis A
    Hum Mol Genet; 2009 Apr; 18(7):1332-42. PubMed ID: 19153073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic predisposition to breast cancer: past, present, and future.
    Turnbull C; Rahman N
    Annu Rev Genomics Hum Genet; 2008; 9():321-45. PubMed ID: 18544032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy in the treatment of hereditary breast cancer.
    Pierce LJ; Haffty BG
    Semin Radiat Oncol; 2011 Jan; 21(1):43-50. PubMed ID: 21134653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of DNA methylation and risk of cardiovascular disease in a Chinese population.
    Gao Y; Pang H; Chen B; Wu C; Wang Y; Hou L; Wang S; Sun D; Zheng X
    BMC Cardiovasc Disord; 2021 May; 21(1):240. PubMed ID: 33980183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
    Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM
    Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study.
    Travis RC; Reeves GK; Green J; Bull D; Tipper SJ; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
    Lancet; 2010 Jun; 375(9732):2143-51. PubMed ID: 20605201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual and joint performance of DNA methylation profiles, genetic risk score and environmental risk scores for predicting breast cancer risk.
    Guan Z; Raut JR; Weigl K; Schöttker B; Holleczek B; Zhang Y; Brenner H
    Mol Oncol; 2020 Jan; 14(1):42-53. PubMed ID: 31677238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
    Hsu HM; Wang HC; Chen ST; Hsu GC; Shen CY; Yu JC
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2024-32. PubMed ID: 17932350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.
    Einarsdóttir K; Rosenberg LU; Humphreys K; Bonnard C; Palmgren J; Li Y; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
    Breast Cancer Res; 2006; 8(6):R67. PubMed ID: 17132159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.